• Thanos Athanasiou, Hutan Ashrafian, Simon P Rowland, and Roberto Casula.
• Department of Surgery & Cancer, Imperial College London, London W2 1NY, UK. t.athanasiou@imperial.ac.uk
• Future Cardiol. 2011 Jul 1; 7 (4): 511-22.

AbstractRobotic cardiac surgery utilizes the most advanced surgical technology to offer patients a minimally invasive alternative to open surgery in the treatment of a broad range of cardiac pathologies. Although robotics may offer substantial benefits to physicians, patients and healthcare institutions, there are important barriers to its adoption that includes inadequate funding, competition from alternate therapies and challenges in training. There is a growing body of evidence to demonstrate the efficacy of robotic cardiac surgery. Technological innovations are improving patient safety and expanding the indications for robotic cardiac surgery beyond the treatment of mitral valve and coronary artery disease. Robotic cardiac surgery is rapidly becoming a feasible, safe and effective option for the definitive treatment of cardiac disease in the context of 21st century challenges to healthcare provision such as diabetes, obesity and an aging population.

7 keywords...

hide…